Stipple Bio

Cambridge, United States

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Apr 2026

Series A

Top Investors

RA Capital ManagementGoogle VenturesOMX VenturesEmerson CollectiveNextech Invest

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Stipple Bio's investors?

Stipple Bio's investors include RA Capital Management, Google Ventures, OMX Ventures, Emerson Collective, Nextech Invest.

Where is Stipple Bio headquartered?

Stipple Bio is headquartered in Cambridge, United States.

What does Stipple Bio do?

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

What stage is Stipple Bio at?

Stipple Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 6, 2026.

MLA

"Stipple Bio — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/stipple-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Stipple Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/stipple-bio

Wikipedia (cite web)

{{cite web |title=Stipple Bio — Funding & Investors |url=https://www.vcbacked.co/company/stipple-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 6, 2026.